Simplex Trading
LLY icon

Simplex Trading’s Eli Lilly LLY Stock Holding History

Simplex Trading’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$102M Sell
111,200
-85,300
-43% -$86.5M 0.07% 113
2025
Q4 		$211M Sell
196,500
-38,800
-16% -$37.1M 0.12% 72
2025
Q3 		$180M Sell
235,300
-159,800
-40% -$119M 0.09% 100
2025
Q2 		$308M Buy
395,100
+172,500
+77% +$134M 0.18% 58
2025
Q1 		$184M Sell
222,600
-197,800
-47% -$165M 0.12% 77
2024
Q4 		$325M Buy
420,400
+148,000
+54% +$123M 0.18% 56
2024
Q3 		$241M Sell
272,400
-66,000
-20% -$59.3M 0.14% 71
2024
Q2 		$306M Sell
338,400
-151,600
-31% -$121M 0.19% 51
2024
Q1 		$381M Buy
490,000
+29,800
+6% +$21.2M 0.22% 47
2023
Q4 		$268M Buy
460,200
+95,500
+26% +$55.7M 0.17% 57
2023
Q3 		$196M Buy
364,700
+54,000
+17% +$27.8M 0.15% 56
2023
Q2 		$146M Buy
310,700
+95,200
+44% +$39.9M 0.12% 84
2023
Q1 		$74M Buy
215,500
+35,700
+20% +$12M 0.07% 208
2022
Q4 		$65.8M Sell
179,800
-50,300
-22% -$17.8M 0.07% 220
2022
Q3 		$74.4M Buy
230,100
+77,900
+51% +$24.7M 0.08% 167
2022
Q2 		$49.3M Buy
152,200
+93,400
+159% +$28M 0.05% 248
2022
Q1 		$16.8M Sell
58,800
-51,000
-46% -$13.1M 0.02% 603
2021
Q4 		$30.3M Sell
109,800
-87,200
-44% -$22.1M 0.03% 376
2021
Q3 		$45.5M Buy
197,000
+7,300
+4% +$1.8M 0.04% 262
2021
Q2 		$43.5M Buy
189,700
+187,475
+8,426% +$37.7M 0.04% 266
2021
Q1 		$41.6M Buy
2,225
+629
+39% +$123K 0.07% 155
2020
Q4 		$26.9M Buy
1,596
+983
+160% +$147K 0.03% 284
2020
Q3 		$9.07M Sell
613
-365
-37% -$56.5K 0.01% 556
2020
Q2 		$16.1M Sell
978
-1,022
-51% -$157K 0.03% 362
2020
Q1 		$27.7M Buy
2,000
+189
+10% +$26K 0.05% 188
2019
Q4 		$23.8M Buy
1,811
+407
+29% +$47.2K 0.05% 240
2019
Q3 		$15.7M Sell
1,404
-225
-14% -$25.1K 0.04% 288
2019
Q2 		$18M Buy
1,629
+178
+12% +$21K 0.05% 256
2019
Q1 		$18.8M Sell
1,451
-802
-36% -$97.5K 0.05% 228
2018
Q4 		$26.1M Buy
2,253
+258
+13% +$28.8K 0.08% 162
2018
Q3 		$21.4M Buy
1,995
+342
+21% +$34.2K 0.07% 199
2018
Q2 		$14.1M Sell
1,653
-310
-16% -$25.5K 0.06% 249
2018
Q1 		$119K Buy
1,963
+1,019
+108% +$82K 0.01% 1663
2017
Q4 		$86K Buy
944
+151
+19% +$12.8K ﹤0.01% 1925
2017
Q3 		$260K Sell
793
-68
-8% -$5.58K 0.01% 1035
2017
Q2 		$177K Sell
861
-953
-53% -$77.7K 0.01% 1277
2017
Q1 		$487K Sell
1,814
-520
-22% -$41.6K 0.02% 687
2016
Q4 		$374K Sell
2,334
-422
-15% -$31.4K 0.02% 691
2016
Q3 		$710K Buy
2,756
+602
+28% +$48.2K 0.05% 366
2016
Q2 		$444K Buy
2,154
+164
+8% +$12.3K 0.03% 574
2016
Q1 		$204K Buy
1,990
+478
+32% +$36.2K 0.02% 869
2015
Q4 		$267K Sell
1,512
-1,329
-47% -$110K 0.02% 696
2015
Q3 		$547K Buy
2,841
+2,256
+386% +$190K 0.04% 412
2015
Q2 		$323K Sell
585
-259
-31% -$19.7K 0.03% 546
2015
Q1 		$104K Buy
844
+738
+696% +$52.5K 0.01% 1079
2014
Q4 		$52K Buy
+106
New +$7.16K 0.01% 1356

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $84.5B AUM 11.36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Simplex Trading's LLY Position: Q1 2026 in Review

Simplex Trading sold out of Eli Lilly (LLY) in Q1 2026, closing a stake of 1,899 shares — an estimated $1.93M sold.

Simplex Trading first reported a position in LLY in Q4 2014 and held it in 21 quarters. The position peaked at $28.1M in Q1 2024. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Simplex Trading reported no remaining Eli Lilly position as of Q1 2026 after selling out during the quarter.
  • Simplex Trading sold 1,899 Eli Lilly shares in Q1 2026, an estimated $1.93M.
  • Simplex Trading first reported a position in Eli Lilly in Q4 2014 and held it in 21 quarters.
  • Simplex Trading's Eli Lilly position peaked at $28.1M in Q1 2024.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.